{"schema_version":"1","generated_at":"2026-10-29T13:00:40.441Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lode-swinnen","json_url":"https://www.findmykol.com/kol/lode-swinnen/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lode-swinnen","name":"Lode Swinnen","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Johns Hopkins University","institution_url":"https://www.findmykol.com/institution/johns-hopkins-university-school-of-medicine","city":"Baltimore","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1417988148","openalex":"A5114029200"},"summary":"Lode Swinnen is an Oncology physician affiliated with Johns Hopkins University. OpenAlex indexes 214 publications with 12,107 citations (h-index 53); ClinicalTrials.gov lists 10 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":214,"cited_by_count":12107,"h_index":53,"latest_activity_year":2024,"source":"works"},"trials":{"count":10,"shown":3,"withheld":9,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05025423","title":"Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT05025423","trial_url":"https://www.findmykol.com/trial/NCT05025423"},{"nct":"NCT02029638","title":"BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT02029638","trial_url":"https://www.findmykol.com/trial/NCT02029638"},{"nct":"NCT00809341","title":"R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT00809341","trial_url":"https://www.findmykol.com/trial/NCT00809341"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"ADC Therapeutics America, Inc.","program_year":2024,"amount_usd":150,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417988148"},{"payer":"ADC Therapeutics America, Inc.","program_year":2023,"amount_usd":10862.94,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417988148"},{"payer":"MorphoSys, US Inc.","program_year":2023,"amount_usd":83.38,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417988148"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417988148","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Musculoskeletal","share_pct":100,"classes_total":1,"classes":[{"class":"Xanthine oxidase inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Allopurinol","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2023,"office_pct":53.4,"facility_pct":46.6},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2007,"last":2007},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"M01RR000052","title":"IDEC-Y2B8","fiscal_year":2007,"amount_usd":"600","organization":"JOHNS HOPKINS UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/M01RR000052"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022","year":2023,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2023.0002","status":"verified"},{"title":"NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023","year":2023,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2023.0057","status":"verified"},{"title":"NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021","year":2021,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2021.0054","status":"verified"},{"title":"Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","year":2020,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2020.0052","status":"verified"},{"title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","year":2020,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2020001729","status":"verified"}],"source":"works"},"contact":{"address_1":"600 N WOLFE ST","city":"Baltimore","state":"MD","zip":"212870005","phone":"410-955-8964","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1417988148","source":"identity"},"similar":[{"name":"Daniel Laheru","slug":"daniel-laheru","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/daniel-laheru","json_url":"https://www.findmykol.com/kol/daniel-laheru/profile.json"},{"name":"Demosthenes G. Katritsis","slug":"demosthenes-katritsis","institution":"Johns Hopkins University","url":"https://www.findmykol.com/kol/demosthenes-katritsis","json_url":"https://www.findmykol.com/kol/demosthenes-katritsis/profile.json"},{"name":"Tanguy Seiwert","slug":"tanguy-seiwert","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/tanguy-seiwert","json_url":"https://www.findmykol.com/kol/tanguy-seiwert/profile.json"},{"name":"Evan Lipson","slug":"evan-lipson","institution":"Johns Hopkins University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/evan-lipson","json_url":"https://www.findmykol.com/kol/evan-lipson/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":9,"payments":6,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-09-06","provider_certified":"2022-09-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}